Germany's vaccine rollout has a healthcare.gov problem

Germany was one of the international stars of the early response to the COVID-19 pandemic last year thanks to a renowned contact tracing system that kept infection rates low, but its vaccine rollout is not going so well. So far, the country has only administered 6.2 million doses, well below the 21 million in the United Kingdom, which began its drive a few weeks earlier, but has a smaller population.
One of the big issues is how difficult it is to sign up for an appointment in the first place, at least in some regions of the country. Reports the Financial Times, the registration portal requires 10 online steps, including a two-step authentication process. For months, the website would also only allow people to sign up for one appointment, even though two doses of the vaccines available in Germany are required for full inoculation, and if everything is booked, there's no waiting list people to notify people when more doses become available. "It's totally amateurish and incredibly inflexible," one German health official told FT.
The jumbled nature of the system is giving some Americans "flashbacks" to the highly-anticipated healthcare.gov launch in 2013, which was tainted by a variety of technical difficulties and an incomplete website design that made it challenging for people to sign up for their health insurance. Read more at The Financial Times. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
What is JD Vance's Net Worth?
In Depth The vice president is rich. But not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
How to travel in the wake of a natural disaster
The Week Recommends Stay safe while being respectful
By Catherine Garcia, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published